Acerus Pharmaceuticals Corporation ASP-CA:Toronto Stock Exchange

*Data is delayed | CAD
Last | 06/29/22 EDT
3.10UNCH (UNCH)
Volume
43
52 week range
2.25 - 11.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.10
  • 52 Week High11.00
  • 52 Week High Date06/29/21
  • 52 Week Low2.25
  • 52 Week Low Date06/24/22

Key Stats

  • Market Cap13.41M
  • Shares Out7.69M
  • 10 Day Average Volume509.6
  • Dividend-
  • Dividend Yield-
  • Beta1.16
  • YTD % Change-38

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.10
  • 52 Week High11.00
  • 52 Week High Date06/29/21
  • 52 Week Low2.25
  • 52 Week Low Date06/24/22
  • Market Cap13.41M
  • Shares Out7.69M
  • 10 Day Average Volume509.6
  • Dividend-
  • Dividend Yield-
  • Beta1.16
  • YTD % Change-38

RATIOS/PROFITABILITY

  • EPS (TTM)-4.54
  • P/E (TTM)-0.68
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Acerus Pharmaceuticals Corporation

There is no recent news for this security.

Content From Our Affiliates

Profile

MORE
Acerus Pharmaceuticals Corporation is a Canada-based specialty pharmaceutical company. The Company is focused on the commercialization and development of prescription products with a primary focus in the field of men's health. Its product, Natesto, is a testosterone nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism. It has two product pipelines, such as avanafil, which is a chemical entity PDE5 inhibitor for the treatment of erectile...
Ian Ihnatowycz
Chairman of the Board
Sam Herschkowitz
Vice Chairman of the Board
Edward Gudaitis
President, Chief Executive Officer, Director
Robert Motz CPA
Chief Financial Officer
Philippe Savard
Vice President, General Counsel, Corporate Secretary
Address
7025 Langer Drive, Suite 205
Mississauga, ON
L5N 0E8
Canada

Top Peers

SYMBOLLASTCHG%CHG
NEPT
Neptune Wellness Solutions Inc
1.34-0.05-3.93%
ACST
Acasti Pharma Inc
0.868+0.0101+1.18%
MRV
Nuvo Pharmaceuticals Inc
0.68+0.01+1.49%
CPH
MDP